VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $3,224,000 | +56.9% | 186,346 | +0.0% | 0.00% | 0.0% |
Q1 2017 | $2,055,000 | -25.1% | 186,265 | -1.4% | 0.00% | 0.0% |
Q4 2016 | $2,743,000 | -43.1% | 188,932 | -3.7% | 0.00% | -50.0% |
Q3 2016 | $4,818,000 | +49.6% | 196,244 | +22.7% | 0.00% | 0.0% |
Q2 2016 | $3,221,000 | -41.4% | 159,936 | -23.5% | 0.00% | -33.3% |
Q1 2016 | $5,496,000 | -98.8% | 208,965 | -95.3% | 0.00% | -98.7% |
Q4 2015 | $447,890,000 | -40.6% | 4,406,208 | +4.2% | 0.24% | -43.4% |
Q3 2015 | $754,581,000 | -99.9% | 4,230,186 | -1.9% | 0.42% | -13.3% |
Q2 2015 | $958,048,978,000 | -0.6% | 4,312,622 | -11.2% | 0.49% | -0.2% |
Q1 2015 | $964,208,735,000 | +22.0% | 4,854,540 | -12.1% | 0.49% | +21.4% |
Q4 2014 | $790,485,401,000 | +105777.9% | 5,523,621 | -2.9% | 0.40% | +1.8% |
Q3 2014 | $746,601,000 | +2.1% | 5,690,564 | -1.8% | 0.40% | +3.4% |
Q2 2014 | $731,133,000 | -99.9% | 5,797,126 | -1.1% | 0.38% | -9.5% |
Q1 2014 | $772,485,174,000 | +2.4% | 5,859,707 | -8.8% | 0.42% | -0.2% |
Q4 2013 | $754,116,318,000 | +12.1% | 6,423,478 | -0.3% | 0.42% | +1.4% |
Q3 2013 | $672,511,389,000 | +21.2% | 6,446,002 | -0.0% | 0.42% | +11.2% |
Q2 2013 | $555,078,358,000 | – | 6,448,401 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |